Wave Life Sciences, Inc. (WVE) Historical Stock Prices
Wave Life Sciences, Inc. (WVE) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: WVE
CIK: 1631574
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerMark Valentine
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| ARS | 2026-10-14 | 2025-12-31 | ARS | 0001193125-26-421815 | View SEC Doc Filr Page |
| DEF 14A | 2026-10-14 | 2026-11-12 | DEF 14A | 0001193125-26-421806 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | 4 Filing | 0001231919-26-001433 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | 4 | 0001193125-26-417237 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | 4 | 0001193125-26-417236 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | 4 | 0001193125-26-417235 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | 4 | 0001193125-26-417234 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | 4 | 0001193125-26-417233 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | 4 | 0001193125-26-417231 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | 4 | 0001193125-26-417232 | View SEC Doc Filr Page |
| EFFECT | 2026-08-14 | — | EFFECT Filing | 9999999995-26-002660 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | 4 | 0001193125-26-349963 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-12 | 4 | 0001193125-26-349962 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | 4 | 0001193125-26-349961 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | 4 | 0001193125-26-349960 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001950047-26-008025 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-11 | — | SCHEDULE 13D/A Filing | 0001346824-26-000222 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001950047-26-007963 | View SEC Doc Filr Page |
| 15-12G | 2026-08-10 | — | 15-12G | 0001193125-26-340683 | View SEC Doc Filr Page |
| POS AM | 2026-08-10 | — | POS AM | 0001193125-26-340682 | View SEC Doc Filr Page |
| POSASR | 2026-08-10 | — | POSASR | 0001193125-26-340679 | View SEC Doc Filr Page |
| S-8 POS | 2026-08-10 | — | S-8 POS | 0001193125-26-340676 | View SEC Doc Filr Page |
| S-8 POS | 2026-08-10 | — | S-8 POS | 0001193125-26-340673 | View SEC Doc Filr Page |
| S-8 POS | 2026-08-10 | — | S-8 POS | 0001193125-26-340670 | View SEC Doc Filr Page |
| S-8 POS | 2026-08-10 | — | S-8 POS | 0001193125-26-340669 | View SEC Doc Filr Page |